| Regulatory mechanisms in the luminal and portal release of vasoactive intestinal polypeptide during vagal nerve stimulation in the cat. | |
| | |
MedLine Citation:
|
PMID: 2907169 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effect of vagal stimulation in chloralose-anesthetized cats on release of vasoactive intestinal polypeptide into the jejunal lumen and portal venous blood was tested simultaneously, and the effect of atropine and hexamethonium was investigated to elucidate the regulatory mechanisms involved in the release. Vagal stimulation caused a significant increase in vasoactive intestinal polypeptide concentrations in the luminal perfusates. A significant concomitant increase was seen in portal plasma. Gel filtration chromatography of luminal and portal samples demonstrated that the vasoactive intestinal polypeptide coeluted with synthetic porcine vasoactive intestinal polypeptide. Vasoactive intestinal polypeptide infusion at 80 and 160 pmol/kg.min produced portal plasma levels of at least 3000 pM but did not increase vasoactive intestinal polypeptide concentrations in the luminal perfusates. Thus, luminal vasoactive intestinal polypeptide originates from gastrointestinal tissue rather than by transduction from the circulation. Vagally induced release of vasoactive intestinal polypeptide into the lumen and portal plasma was not abolished by atropine but was totally suppressed by hexamethonium. The regulatory mechanisms controlling the parallel release of vasoactive intestinal polypeptide into both the jejunal lumen and portal circulation are identical and involve a non-muscarinic process which is under cholinoceptive, nicotinic control. |
| | |
Authors:
|
M A Blank; K Kimura; B M Jaffe |
Related Documents
:
|
11129219 - Determinants of basal plasma gastrin levels in the general population. 6514999 - Motilin and migrating myoelectric complexes in the pig and the dog. 7124279 - Ontogeny of circulating gastrin and pancreatic polypeptide in the foetal sheep. 2921489 - Is the gastrin response to secretin provocation a function of antral g-cell mass? resul... 549429 - Fasting serum gastrin in primary hyperparathyroidism and in chronic hypercalcemia. 8194689 - Satiety effects of cholecystokinin in humans. 1491509 - Chronopharmacology of furosemide in rats with amikacin-induced acute renal damage. 9627369 - Effect of glucagon on the plasma concentration of uridine. 762949 - Comparison of phenytoin determinations in plasma, plasma dialysate and saliva for contr... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Regulatory peptides Volume: 23 ISSN: 0167-0115 ISO Abbreviation: Regul. Pept. Publication Date: 1988 Oct |
Date Detail:
|
Created Date: 1989-04-26 Completed Date: 1989-04-26 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8100479 Medline TA: Regul Pept Country: NETHERLANDS |
Other Details:
|
Languages: eng Pagination: 15-26 Citation Subset: IM |
Affiliation:
|
Department of Surgery, State University of New York Health Science Center, Brooklyn 11203. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Atropine / pharmacology Cats Electric Stimulation Hexamethonium Hexamethonium Compounds / pharmacology Jejunum / drug effects, physiology* Kinetics Male Reference Values Vagus Nerve / physiology* Vasoactive Intestinal Peptide / blood, secretion* |
| Chemical | |
Reg. No./Substance:
|
0/Hexamethonium Compounds; 37221-79-7/Vasoactive Intestinal Peptide; 51-55-8/Atropine; 60-26-4/Hexamethonium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The effects of somatostatin on the arachidonate cascade of platelets.
Next Document: Variations of plasma immunoreactive motilin, pancreatic polypeptide, gastrin and somatostatin along ...